MASSDEVICE ON CALL — Global technology titan Honda (NYSE:HMC) this month announced the 1st large-scale clinical study of its Walking Assist Device, a battery- and motor-powered exoskeleton that the company called “stylish.”
The technology was designed to assist patients with reduced mobility due to illness, stroke or other causes, featuring “cooperative control technology” that activates motors based on hip angle sensors, similar to what the company used in its ASIMO humanoid robot.
Help employers find you! Check out all the jobs and post your resume.
